跳至主要内容
临床试验/NCT03139240
NCT03139240已完成4 期

Opioid Analgesia for MAB: A Randomized Controlled Trial

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
172
试验地点
1
主要终点
<7 Weeks of Gestation - Maximum Self-reported Pain Score

研究概览

简要总结

Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study will help future providers understand whether prescribing opioids are an important adjunct for pain control in women undergoing MAB.

详细描述

This study will include 152 women undergoing MAB. Women will be randomized to oxycodone 10mg oral versus placebo and stratified by gestational age (<7wks, 7-10wks). The primary outcome will be maximum reported pain score measured at 6-8 hours and 24 hours after misoprostol administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double Blind

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Seeking elective medical abortion
  • In good health
  • Pregnancy with intrauterine gestational sac up to 10 0/7 weeks, dated by ultrasound
  • Able and willing to receive text messages via phone
  • Literate in English
  • Able and willing to give informed consent and agree to the study terms
  • Have assistance at home; no motor vehicle use while taking study medications

排除标准

  • Lack of access to cell phone and texting capabilities
  • Early pregnancy failure
  • Contraindications to the study medications: Oxycodone, Ibuprofen
  • Contraindications to medical abortion with Mifepristone or Misoprostol
  • History of methadone or heroin use
  • Used alcohol in the past 24 hours
  • Used marijuana >4 times per week
  • Any opioid in the past 30 days
  • Using additional pain medications

研究组 & 干预措施

Gestational age <7 weeks

Experimental

Women with a gestational age <7 weeks will be randomized to oxycodone 10mg oral vs placebo

干预措施: Oxycodone 10mg oral (Drug)

Gestational age <7 weeks

Experimental

Women with a gestational age <7 weeks will be randomized to oxycodone 10mg oral vs placebo

干预措施: Placebo (Other)

Gestational age 7-10w0d

Experimental

Women with a gestational age 7-10w0d will be randomized to oxycodone 10mg oral vs placebo

干预措施: Oxycodone 10mg oral (Drug)

Gestational age 7-10w0d

Experimental

Women with a gestational age 7-10w0d will be randomized to oxycodone 10mg oral vs placebo

干预措施: Placebo (Other)

结局指标

主要结局

<7 Weeks of Gestation - Maximum Self-reported Pain Score

时间窗: 24 hours after misoprostol administration

Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self-reported pain score on an 11-point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain).

7-10 Weeks Gestation - Maximum Self-reported Pain Score

时间窗: 24 hours after misoprostol administration

Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self-reported pain score on an 11-point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain).

Overall Maximum Self-reported Pain Score

时间窗: 24 hours after misoprostol administration

Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self-reported pain score on an 11-point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alyssa Colwill

MD, Instructor

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验